CRED, a leading Egyptian pharmaceutical company, has recently launched a new compound called Ever. This innovative drug is designed to treat a range of medical conditions, including chronic pain, inflammation, and fever. Ever is a non-steroidal anti-inflammatory drug (NSAID) that works by blocking the production of prostaglandins, which are responsible for causing pain and inflammation in the body.
One of the key benefits of Ever is that it is highly effective at reducing pain and inflammation, while also being safe and well-tolerated by patients. Unlike many other NSAIDs, Ever does not cause significant gastrointestinal side effects, such as stomach ulcers and bleeding. This makes it a particularly attractive option for patients who suffer from chronic pain and inflammation, but are unable to tolerate other NSAIDs due to their side effects.
Another advantage of Ever is that it is available in a range of formulations, including tablets, capsules, and injections. This makes it easy for doctors to prescribe the drug in the most appropriate form for each patient's individual needs. In addition, Ever has a long half-life, which means that it can be taken less frequently than other NSAIDs, reducing the risk of side effects and improving patient compliance.